Endoluminal procedures for bariatric patients: expectations among bariatric surgeons |
| |
| Authors: | Stacy A. Brethauer Aurora D. Pryor Bipan Chand Philip Schauer Raul Rosenthal William Richards Marc Bessler |
| |
| Affiliation: | 1. Laval University Cancer Research Center, Hôtel-Dieu-de-Québec, Centre Hospitalier Universitaire (CHU) de Québec, Québec, Québec, Canada, G1R 2 J6;2. Anatomic Pathology and Cytology Department, Hôpital du St-Sacrement, Centre Hospitalier Universitaire (CHU) de Québec, Laval University, Québec, Québec, Canada, G1S 4 L8;3. Department of Pathology, Centre Hospitalier Universitaire de Montréal, Montreal, Québec, Canada, H2X 3 J4;4. The Research Centre of the University of Montreal Teaching Hospital (CR-CHUM)/Montreal Cancer Institute, Montreal, Québec, Canada, H2X 0A9;5. Department of Pathology and Cellular Biology, University of Montreal, Montreal, Québec, Canada, H3T 1 J4;6. Gynecologic Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec, L''Hôtel-Dieu-de-Québec, Québec, Québec, Canada, G1R 2 J6;1. Charlie Norwood Veterans Administration Medical Center, Augusta, Georgia;2. Center for Pharmacy and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, Georgia;3. Department of Physiology, Georgia Regents University, Augusta, Georgia |
| |
| Abstract: | BackgroundPrimary and revisional bariatric endoluminal procedures are currently being developed. Acceptable levels of risk and weight loss for these procedures have not yet been established. The aim of this study was to evaluate the expectations and concerns among bariatric surgeons regarding these procedures.MethodsThe American Society for Metabolic and Bariatric Surgery Emerging Technologies Committee developed a questionnaire that was distributed to the membership. Risk tolerance was assessed with comparison to commonly performed endoscopic and bariatric procedures. The percentage of excess weight loss (EWL) ranges were provided to assess the expectations for results 1 year after the procedure.ResultsA total of 214 responses were returned. The acceptable level of risk to achieve 10–20% EWL after primary and revisional procedures was equivalent to, or less than, that of a therapeutic endoscopic procedure for 81% and 76% of respondents, respectively. The acceptable level of risk to achieve 30–40% EWL after primary and revisional procedures was equivalent to that after laparoscopic adjustable gastric banding for 45% and 35% of respondents, respectively and equivalent to that after laparoscopic Roux-en-Y gastric bypass for 8% and 22%, respectively. In addition, 62% of respondents responded that 10–30% EWL would be acceptable for revisional procedures, and 35% responded that 10–30% EWL would be acceptable after a primary procedure. The primary concern was unproven efficacy, followed by durability, poor weight loss, availability of equipment, and procedural risk. Finally, 58% would not be willing to recommend an endoluminal procedure until the efficacy has been established, regardless of the risk.ConclusionRisk tolerance and weight loss expectations among bariatric surgeons are different for primary and revisional endoscopic procedures. Most surgeons were unwilling to consider endoluminal procedures for their patients until the efficacy has been proven. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
